Skip to main content
Equibles
DMRA logo

DMRA · Damora Therapeutics, Inc. · Suppliers & Customers

Track DMRA — free

Use DMRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DMRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$21.96 +0.70 (+3.29%) At close · Oct 27
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 10, 2026
Market Cap
$1.36B
Shares
61.74M
Volume · Oct 27 286.1K Avg daily vol (3M) 520.19K

Supply Chain

Customers, suppliers, competitors and partners, private companies included: the ones DMRA names, and the companies that name DMRA.

Read supply chains in your AI or your code through MCP and the API →
Diagram Table Overlap
Pro

See who DMRA sells to, buys from, competes and partners with

  • 2 suppliers
  • 0 customers
  • 10 competitors
  • 1 partner

Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.

View plans
Key facts CIK 1800315 CUSIP G2646Y104 13F (30d) 7 filings 7 filers Visit website Investor relations